BON Announces Nasdaq Compliance
Bon Natural Life (Nasdaq: BON), a bio-ingredient solution provider in the natural, health and personal care industry, has successfully regained compliance with Nasdaq's continued listing requirements. The company received formal confirmation from the Nasdaq Hearings Panel on July 2, 2025, verifying that BON has met the Minimum Bid Price Requirement under Nasdaq Listing Rule 5550(a)(2).
Following BON's compliance plan submission on May 16, 2025, and a hearing presentation on June 5, 2025, the Panel granted the company's request to maintain its Nasdaq Capital Market listing. BON will remain under a Discretionary Panel Monitor for one year to ensure ongoing compliance with listing standards.
Bon Natural Life (Nasdaq: BON), fornitore di soluzioni bio-ingredienti nel settore naturale, della salute e della cura personale, ha riconquistato con successo la conformità ai requisiti di quotazione continuativa del Nasdaq. La società ha ricevuto la conferma ufficiale dal Nasdaq Hearings Panel il 2 luglio 2025, attestando che BON ha soddisfatto il requisito del prezzo minimo per azione previsto dalla Regola di Quotazione Nasdaq 5550(a)(2).
Dopo la presentazione del piano di conformità di BON il 16 maggio 2025 e l’audizione del 5 giugno 2025, il Panel ha concesso la richiesta dell’azienda di mantenere la quotazione sul Nasdaq Capital Market. BON resterà sotto la supervisione di un Discretionary Panel Monitor per un anno, a garanzia del rispetto continuo degli standard di quotazione.
Bon Natural Life (Nasdaq: BON), proveedor de soluciones bioingredientes en la industria natural, de salud y cuidado personal, ha recuperado con éxito el cumplimiento de los requisitos continuos de cotización del Nasdaq. La compañía recibió la confirmación formal del Nasdaq Hearings Panel el 2 de julio de 2025, verificando que BON cumplió con el Requisito de Precio Mínimo según la Regla de Cotización Nasdaq 5550(a)(2).
Tras la presentación del plan de cumplimiento de BON el 16 de mayo de 2025 y la audiencia del 5 de junio de 2025, el Panel aprobó la solicitud de la compañía para mantener su cotización en el Nasdaq Capital Market. BON permanecerá bajo la supervisión de un Discretionary Panel Monitor durante un año para asegurar el cumplimiento continuo de las normas de cotización.
Bon Natural Life (나스닥: BON)는 자연, 건강 및 개인 관리 산업의 바이오 성분 솔루션 제공업체로서 나스닥 상장 유지 요건을 성공적으로 충족했습니다. 회사는 2025년 7월 2일 나스닥 심의위원회로부터 BON이 나스닥 상장 규칙 5550(a)(2)에 따른 최저 입찰 가격 요건을 충족했음을 공식 확인받았습니다.
BON은 2025년 5월 16일에 준수 계획을 제출하고 2025년 6월 5일 청문회 발표를 한 후, 위원회로부터 나스닥 자본시장 상장을 유지할 수 있는 승인을 받았습니다. BON은 상장 기준의 지속적인 준수를 보장하기 위해 1년 동안 재량 위원회 모니터의 감독을 받게 됩니다.
Bon Natural Life (Nasdaq : BON), fournisseur de solutions bio-ingrédients dans les secteurs naturel, santé et soins personnels, a réussi à retrouver la conformité aux exigences de cotation continue du Nasdaq. La société a reçu la confirmation officielle du Nasdaq Hearings Panel le 2 juillet 2025, attestant que BON a satisfait à l'exigence de prix minimum selon la règle de cotation Nasdaq 5550(a)(2).
Suite à la soumission du plan de conformité de BON le 16 mai 2025 et à une audition le 5 juin 2025, le Panel a accordé la demande de la société de maintenir sa cotation sur le Nasdaq Capital Market. BON restera sous la surveillance d'un Discretionary Panel Monitor pendant un an afin d'assurer le respect continu des normes de cotation.
Bon Natural Life (Nasdaq: BON), ein Anbieter von Bio-Inhaltsstofflösungen in der Natur-, Gesundheits- und Körperpflegebranche, hat erfolgreich die Einhaltung der fortlaufenden Notierungsanforderungen der Nasdaq wiedererlangt. Das Unternehmen erhielt am 2. Juli 2025 eine formelle Bestätigung vom Nasdaq Hearings Panel, dass BON die Mindestgebotspreisanforderung gemäß Nasdaq Listing Rule 5550(a)(2) erfüllt hat.
Nach Einreichung des Compliance-Plans von BON am 16. Mai 2025 und einer Anhörung am 5. Juni 2025 genehmigte das Panel den Antrag des Unternehmens, die Notierung am Nasdaq Capital Market beizubehalten. BON wird für ein Jahr unter der Aufsicht eines Discretionary Panel Monitor stehen, um die fortlaufende Einhaltung der Notierungsstandards sicherzustellen.
- Successfully regained Nasdaq listing compliance
- Maintained listing on Nasdaq Capital Market
- Approval of compliance plan by Nasdaq Hearings Panel
- Company will remain under one-year Discretionary Panel Monitor
- Previous non-compliance with minimum bid price requirement
On July 2, 2025, the Company received formal notice from the Nasdaq Hearings Panel confirming that BON has successfully met the Minimum Bid Price Requirement under Nasdaq Listing Rule 5550(a)(2). As a result, the Panel has granted the Company's request to maintain its listing on the Nasdaq Capital Market.
BON submitted its plan of compliance to Nasdaq on May 16, 2025, and subsequently presented its case for continued listing during a hearing on June 5, 2025.
As part of the Panel's decision, BON will remain under a Discretionary Panel Monitor for a period of one year, during which time Nasdaq will monitor the Company's ongoing compliance with all continued listing standards.
About Bon Natural Life Limited ("BON")
BON is a
For more information, please contact:
Cindy Liu | IR
Email: bonnatural@appchem.cn
Safe Harbor Statement
This press release contains certain statements that may include "forward-looking statements." All statements other than statements of historical fact included herein are "forward-looking statements." These forward-looking statements are often identified by the use of forward-looking terminology such as "believes", "expects" or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, they do involve assumptions, risks, and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.
View original content:https://www.prnewswire.com/news-releases/bon-announces-nasdaq-compliance-302504096.html
SOURCE Bon Natural Life Limited
FAQ
What did Bon Natural Life (BON) announce regarding Nasdaq compliance on July 14, 2025?
When did BON receive formal notice of Nasdaq compliance?
What monitoring conditions were placed on BON by Nasdaq?
What steps did BON take to regain Nasdaq compliance?
